The DOI matches its Crossref record; 389 of the 389 references it cites were found in a registry or an index.
Platelets and cancer: a casual or causal relationship: revisited
Open accessAbstract
Human platelets arise as subcellular fragments of megakaryocytes in bone marrow. The physiologic demand, presence of disease such as cancer, or drug effects can regulate the production circulating platelets. Platelet biology is essential to hemostasis, vascular integrity, angiogenesis, inflammation, innate immunity, wound healing, and cancer biology. The most critical biological platelet response is serving as “First Responders” during the wounding process. The exposure of extracellular matrix proteins and intracellular components occurs after wounding. Numerous platelet receptors recognize matrix proteins that trigger platelet activation, adhesion, aggregation, and stabilization. Once activated, platelets change shape and degranulate to release growth factors and bioactive lipids into the blood stream. This cyclic process recruits and aggregates platelets along with thrombogenesis. This process facilitates wound closure or can recognize circulating pathologic bodies. Cancer cell entry into the blood stream triggers platelet-mediated recognition and is amplified by cell surface receptors, cellular products, extracellular factors, and immune cells. In some cases, these interactions suppress immune recognition and elimination of cancer cells or promote arrest at the endothelium, or entrapment in the microvasculature, and survival. This supports survival and spread of cancer cells and the establishment of secondary lesions to serve as important targets for prevention and therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–389 of 389
Geddis, A. E. (2010) · Seminars in Hematology · doi:10.1053/j.seminhematol.2010.03.001 · Cited by 133
Chromatin occupancy analysis reveals genome-wide GATA factor switching during hematopoiesis
Doré, L. C., Chlon, T. M., Brown, C. D., White, K. P., & Crispino, J. D. (2012) · Blood · doi:10.1182/blood-2011-09-380634 · Cited by 132
Fredrickson, B. J., Dong, J.-F., McIntire, L. V., & López, J. A. (1998) · Blood · doi:10.1182/blood.v92.10.3684 · Cited by 132
Role of metalloproteinases in platelet function
Santos-Martínez, M. J., Medina, C., Jurasz, P., & Radomski, M. W. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2007.06.002 · Cited by 131
The Role of ITAM- and ITIM-coupled Receptors in Platelet Activation by Collagen
Asazuma, N., Atkinson, B. T., Berlanga, O., Best, D., Bobe, R., Jarvis, G. E., Marshall, S., Snell, D. C., Stafford, M. J., Tulasne, D., et al. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616225 · Cited by 129
Alonso‐Escolano, D., Strongin, A. Y., Chung, A. W. Y., Deryugina, E. I., & Radomski, M. W. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705606 · Cited by 129
Sumner, R., Crawford, A., Mucenski, M. L., & Frampton, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203660 · Cited by 128
Adhesion and homing of blood-borne cells in bone marrow microvessels
Mazo, I. B., & von Andrian, U. H. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.1.25 · Cited by 127
Koziak, K., Sévigny, J., Robson, S. C., et al. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614868 · Cited by 126
Mechanics of proplatelet elaboration
Italiano, J. E., Patel-Hett, S. R., & Hartwig, J. H. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02487.x · Cited by 125
Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury, 5
(2002) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0193-0 · Cited by 124
Release of sphingosine‐1‐phosphate from human platelets is dependent on thromboxane formation
ULRYCH, T., BÖHM, A., POLZIN, A., DAUM, G., NÜSING, R. M., GEISSLINGER, G., HOHLFELD, T., SCHRÖR, K., & RAUCH, B. H. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04194.x · Cited by 124
Syntaxin-11, but not syntaxin-2 or syntaxin-4, is required for platelet secretion
Ye, S., Karim, Z. A., Hawas, R. A., Pessin, J. E., Filipovich, A. H., & Whiteheart, S. W. (2012) · Blood · doi:10.1182/blood-2012-05-430603 · Cited by 124
Pineo, G. F., Regoeczi, E., Hatton, M. W. C., & Brain, M. C. (1973) · PubMed · Cited by 124
Dovizio, M., Maier, T. J., Alberti, S., Francesco, L. D., Marcantoni, E., Münch, G., John, C. M., Suess, B., Sgambato, A., Steinhilber, D., et al. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.084988 · Cited by 123
Dangel, O., Mergia, E., Karlisch, K., Groneberg, D., Koesling, D., & Friebe, A. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03806.x · Cited by 121
Melnikova, V. O., Mourad-Zeidan, A. A., Lev, D. C., & Bar‐Eli, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508683200 · Cited by 119
Platelet Biology and Receptor Pathways
Cimmino, G., & Golino, P. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9445-9 · Cited by 119
Aspirin and cancer risk: an updated quantitative review to 2005
Bosetti, C., Gallus, S., & Vecchia, C. L. (2006) · Cancer Causes & Control · doi:10.1007/s10552-006-0033-7 · Cited by 118
Sabri, S., Jandrot‐Perrus, M., Bertoglio, J. H., Farndale, R. W., Mas, V. M., Debili, N., & Vainchenker, W. (2004) · Blood · doi:10.1182/blood-2003-12-4398 · Cited by 117
Proteomic analysis of palmitoylated platelet proteins
Dowal, L. M., Yang, W., Freeman, M. R., Steen, H., & Flaumenhaft, R. C. (2011) · Blood · doi:10.1182/blood-2011-05-353078 · Cited by 116
Schoels, M., van der Heijde, D. M., Breedveld, F., Burmester, G., Dougados, M., Emery, P., Ferraccioli, G., Gabay, C., Gibofsky, A., Gómez-Reino, J., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202470 · Cited by 115
Activated platelets and monocytes generate four hydroxyphosphatidylethanolamines via lipoxygenase.
Maskrey, B. H., Bermúdez-Fajardo, A., Morgan, A. H., Stewart-Jones, E., Dioszeghy, V., Taylor, G. W., Baker, P. R. S., Coles, B., Coffey, M. J., Kühn, H., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.a611776200 · Cited by 115
Honn, K. V., Tang, D. G., Grossi, I. M., Duniec, Z. M., Tímár, J., Renaud, C., Leithauser, M. T., Blair, I. A., Johnson, C. R., & Diglio, C. A. (1994) · PubMed · Cited by 115
Self-citationThe Platelet: Form and Function
Hartwig, J. H. (2006) · Seminars in Hematology · doi:10.1053/j.seminhematol.2005.11.004 · Cited by 115
Falanga, A., Consonni, R., Marchetti, M., Locatelli, G., Garattini, E., Gambacorti-Passerini, C. B., Gordon, S. G., & Barbui, T. (1998) · Blood · doi:10.1182/blood.v92.1.143.413k18_143_151 · Cited by 115
Habets, K. L. L., Huizinga, T. W. J., & Toes, R. E. M. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12101 · Cited by 114
Ambrosio, A. L., Boyle, J. A., & Pietro, S. M. D. (2012) · Blood · doi:10.1182/blood-2012-04-420745 · Cited by 113
Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q− syndrome
Kumar, M. S., Narla, A., Nonami, A., Mullally, A., Dimitrova, N., Ball, B. J., McAuley, J. R., Poveromo, L., Kutok, J. L., Galili, N., et al. (2011) · Blood · doi:10.1182/blood-2010-12-324715 · Cited by 113
PlateletWeb: a systems biologic analysis of signaling networks in human platelets
Boyanova, D., Nilla, S., Birschmann, I., Dandekar, T., & Dittrich, M. T. (2011) · Blood · doi:10.1182/blood-2011-10-387308 · Cited by 111
Dai, K., Bodnar, R. J., Berndt, M. C., & Du, X. (2005) · Blood · doi:10.1182/blood-2005-01-0440 · Cited by 110
Lipidomic profiling of bioactive lipids by mass spectrometry during microbial infections
Tam, V. C. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.08.006 · Cited by 110
Transcription factors in late megakaryopoiesis and related platelet disorders
Tijssen, M. R., & Ghevaert, C. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12131 · Cited by 109
Platelet-derived microparticles – an updated perspective
Siljander, P. R. M. (2010) · Thrombosis Research · doi:10.1016/s0049-3848(10)70152-3 · Cited by 107
MicroRNAs in platelet production and activation
Edelstein, L. C., McKenzie, S. E., Shaw, C. A., Holinstat, M. A., Kunapuli, S. P., & Bray, P. F. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12214 · Cited by 107
Steitz, J., Br�ck, J., Steinbrink, K., Enk, A., Knop, J. X. F. R., & Tüting, T. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000401)86:1<15::aid-ijc3>3.0.co;2-b · Cited by 106
The physiological and pathophysiological roles of platelet CLEC-2
Langan, S. A., Nash, G. B., Watson, S. P., & Navarro‐Núñez, L. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-01-0060 · Cited by 105
Boyles, J. K., Fox, J. E. B., Phillips, D. R., & Stenberg, P. E. (1985) · The Journal of Cell Biology · doi:10.1083/jcb.101.4.1463 · Cited by 104
Cell cycle synchronization of animal cells and nuclei by centrifugal elutriation
Bánfalvi, G. (2008) · Nature Protocols · doi:10.1038/nprot.2008.34 · Cited by 103
Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside
Deutsch, V. R., & Tomer, A. (2013) · British Journal of Haematology · doi:10.1111/bjh.12328 · Cited by 102
Garcia, M. C., & Kim, H. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00583-0 · Cited by 101
α-Adducin dissociates from F-actin and spectrin during platelet activation
Barkalow, K. L., Italiano, J. E., Chou, D. E., Matsuoka, Y., Bennett, V., & Hartwig, J. H. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200211122 · Cited by 98
Peters, C. G., Michelson, A. D., & Flaumenhaft, R. C. (2012) · Blood · doi:10.1182/blood-2011-10-389247 · Cited by 98
Lectures ON CLINICAL MEDICINE,
Walshe, W. H. (1849) · The Lancet · doi:10.1016/s0140-6736(02)65117-7 · Cited by 97
Pruthi, R. S., Derksen, J. E., Moore, D. T., Carson, C. C., Grigson, G., Watkins, C., & Wallen, E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2067 · Cited by 97
Munc18b/STXBP2 is required for platelet secretion
Hawas, R. A., Ren, Q., Ye, S., Karim, Z. A., Filipovich, A. H., & Whiteheart, S. W. (2012) · Blood · doi:10.1182/blood-2012-05-430629 · Cited by 95
The Elegant Platelet: Signals Controlling Actin Assembly
Barkalow, K., Azim, A., Italiano, J., et al. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615858 · Cited by 94
PSGL-1-dependent myeloid leukocyte activation
Zarbock, A., Müller, H., Kuwano, Y., & Ley, K. F. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0209117 · Cited by 93
Rap1-Rac1 Circuits Potentiate Platelet Activation
Stefanini, L., Boulaftali, Y., Ouellette, T. D., Holinstat, M. A., Désiré, L., Leblond, B., André, P., Conley, P. B., & Bergmeier, W. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.239194 · Cited by 93
Concise Review: Multiple Niches for Hematopoietic Stem Cell Regulations
Oh, I., & Kwon, K.-R. (2010) · Stem Cells · doi:10.1002/stem.453 · Cited by 91
Shai, E., Rosa, I., Parguiña, A. F., Motahedeh, S., Varon, D., & García, Á. G. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.02.030 · Cited by 91
Platelet rich plasma therapy: inflammatory molecules involved in tissue healing.
Galliera, E., Corsi, M. M., & Banfi, G. (2012) · PubMed · Cited by 90
Dilly, A. K., Ekambaram, P., Guo, Y., Cai, Y., Tucker, S. C., Fridman, R. A., Kandouz, M., & Honn, K. V. (2013) · International Journal of Cancer · doi:10.1002/ijc.28165 · Cited by 90
Self-citationClark, S., Thomas, C. P., Hammond, V. J., Aldrovandi, M., Wilkinson, G. W. G., Hart, K. W., Murphy, R. C., Collins, P. W., & O’Donnell, V. B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222419110 · Cited by 90
Anatomy, Physiology, and Pathology of the Blood Supply of Bones
Kelly, P. J. (1968) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-196850040-00015 · Cited by 88
Zhong, J., Gencay, M., Bubendorf, L., Burgess, J. K., Parson, H., Robinson, B. W. S., Tamm, M., Black, J. L., & Roth, M. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20605 · Cited by 88
Harris, R. E., Beebe-Donk, J., & Alshafie, G. A. (2007) · International Journal of Biological Sciences · doi:10.7150/ijbs.3.328 · Cited by 88
Localization of megakaryocytes in the bone marrow.
Tavassoli, M., & Aoki, M. (1989) · PubMed · Cited by 86
The VPS33B-binding protein VPS16B is required in megakaryocyte and platelet α-granule biogenesis
Urban, D., Li, L., Christensen, H., Pluthero, F. G., Chen, S. Z., Puhacz, M., Garg, P. M., Lanka, K., Cummings, J. J., Krämer, H., et al. (2012) · Blood · doi:10.1182/blood-2012-05-431205 · Cited by 86
Essential role of CIB1 in regulating PAK1 activation and cell migration
Leisner, T. M., Liu, M., Jaffer, Z. M., Chernoff, J., & Parise, L. V. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200502090 · Cited by 86
The American Journal of Cancer
(1930) · Radiology · doi:10.1148/15.6.699 · Cited by 86
Radomski, A. S., Jurasz, P., Sanders, E. J., Overall, C. M., Bigg, H. F., Edwards, D. R., & Radomski, M. W. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704936 · Cited by 85
Kaur, G., Jalagadugula, G. S., Mao, G., & Rao, A. K. (2010) · Blood · doi:10.1182/blood-2009-04-214601 · Cited by 84
Bone Marrow Osteoblastic Niche: A New Model to Study Physiological Regulation of Megakaryopoiesis
Pallotta, I., Lovett, M. L., Rice, W., Kaplan, D. L., & Balduini, A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008359 · Cited by 84
Dammacco, F., Vacca, A., Procaccio, P., Ria, R., Marech, I., & Racanelli, V. (2013) · Clinical and Experimental Medicine · doi:10.1007/s10238-013-0230-0 · Cited by 84
The Platelet Cytoskeleton Regulates the Affinity of the Integrin αIIbβ3 for Fibrinogen
BENNETT, J. S., Zigmond, S. H., Vilaire, G., Cunningham, M. E. A., & Bednár̂, B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25301 · Cited by 81
Wraith, K. S., Magwenzi, S., Aburima, A. A., Wen, Y., Leake, D. S., & Naseem, K. M. (2013) · Blood · doi:10.1182/blood-2013-04-491688 · Cited by 81
Physiologically significant effects of pH and oxygen tension on granulopoiesis
Hevehan, D. L., Papoutsakis, E. T., & Miller, W. M. (2000) · Experimental Hematology · doi:10.1016/s0301-472x(99)00150-2 · Cited by 79
Reduced Membrane Fluidity in Platelets From Diabetic Patients
Winocour, P. D., Bryszewska, M. J., Watała, C. W., Rand, M. L., Epand, R. M., Kinlough-Rathbone, R. L., Packham, M. A., & Mustard, J. F. (1990) · Diabetes · doi:10.2337/diab.39.2.241 · Cited by 79
Migrating Thrombophlebitis Associated with Carcinoma
EDWARDS, E. A. (1949) · New England Journal of Medicine · doi:10.1056/nejm194906302402601 · Cited by 79
Kenney, D. M., & Linck, R. W. (1985) · Journal of Cell Science · doi:10.1242/jcs.78.1.1 · Cited by 78
Chlon, T. M., Doré, L. C., & Crispino, J. D. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.05.051 · Cited by 77
Significance of podoplanin expression in cancer-associated fibroblasts: A comprehensive review
Puła, B., Witkiewicz, W., Dzięgiel, P., & Podhorska‐Okołów, M. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1887 · Cited by 76
Kim, C., Lau, T., Ulmer, T. S., & Ginsberg, M. H. (2009) · Blood · doi:10.1182/blood-2008-10-186551 · Cited by 76
Platelet receptors activated via mulitmerization: glycoprotein VI, GPIb‐IX‐V, and CLEC‐2
Ozaki, Y., Suzuki‐Inoue, K., & Inoue, O. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12235 · Cited by 76
Advances in platelet granule biology
Koseoglu, S., & Flaumenhaft, R. C. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283632e6b · Cited by 73
Watson, A. A., Brown, J., Harlos, K., Eble, J. A., Walter, T. S., & O’Callaghan, C. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m610383200 · Cited by 73
Protty, M. B., Watkins, N. A., Colombo, D., Thomas, S. G., Heath, V. L., Herbert, J. M. J., Bicknell, R., Senis, Y. A., Ashman, L. K., Berditchevski, F., et al. (2008) · Biochemical Journal · doi:10.1042/bj20081126 · Cited by 73
RhoA Sustains Integrin αIIbβ3Adhesion Contacts under High Shear
Schoenwaelder, S. M., Hughan, S. C., Boniface, K., Fernando, S., Holdsworth, M., Thompson, P. E., Salem, H. H., & Jackson, S. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200661200 · Cited by 72
Metformin overdose causes platelet mitochondrial dysfunction in humans
Protti, A., Lecchi, A., Fortunato, F., Artoni, A., Greppi, N., Vecchio, S., Fagiolari, G., Moggio, M. G., Comi, G. P., Mistraletti, G., et al. (2012) · Critical Care · doi:10.1186/cc11663 · Cited by 72
Wilson, L. S., Elbatarny, H. S., Crawley, S. W., Bennett, B. M., & Maurice, D. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804738105 · Cited by 72
The glycoprotein Ibα–von Willebrand factor interaction induces platelet apoptosis
Li, S., Wang, Z., LIAO, Y., ZHANG, W., Shi, Q. F., YAN, R., RUAN, C., & Dai, K. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03653.x · Cited by 71
Morgan, L. T., Thomas, C. P., Kühn, H., & O’Donnell, V. B. (2010) · Biochemical Journal · doi:10.1042/bj20100415 · Cited by 71
Unraveling Mechanisms that Control Platelet Production
Italiano, J. E. (2012) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0032-1331157 · Cited by 71
Ikaros inhibits megakaryopoiesis through functional interaction with GATA-1 and NOTCH signaling
Malinge, S., Thiollier, C., Chlon, T. M., Doré, L. C., Diebold, L. P., Bluteau, O., Mabialah, V., Vainchenker, W., Dessen, P., Winandy, S., et al. (2013) · Blood · doi:10.1182/blood-2012-08-450627 · Cited by 70
Crosstalk between cancer and haemostasis
Bokemeyer, C., & Länger, F. P. (2011) · Hämostaseologie · doi:10.5482/ha-1160 · Cited by 70
Akbar, H., Shang, X., Perveen, R., Berryman, M. A., Funk, K. R., Johnson, J. F., Tandon, N. N., & Zheng, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022117 · Cited by 69
The effect of platelets on invasiveness and protease production of human mammary tumor cells
Belloc, C., Lu, H., Soria, C., Fridman, R. A., Legrand, Y., & Ménashi, S. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600324 · Cited by 68
Regulation of hematopoietic stem cells by their mature progeny
de Graaf, C. A., Kauppi, M., Baldwin, T. M., Hyland, C. D., Metcalf, D., Willson, T. A., Carpinelli, M. R., Smyth, G. K., Alexander, W. S., & Hilton, D. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016166108 · Cited by 68
Anti-Platelet and Membrane-Rigidifying Flavonoids in Brownish Scale of Onion
Furusawa, M., Tsuchiya, H., Nagayama, M., Tanaka, T., Nakaya, K., & Iinuma, M. (2003) · Eisei kagaku · doi:10.1248/jhs.49.475 · Cited by 68
Regulators of Platelet cAMP Levels: Clinical and Therapeutic Implications
Noe, L., Peeters, K., Izzi, B., Geet, C. V., & Freson, K. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710792065018 · Cited by 67
Douglas, V. K., Tallman, M. S., Cripe, L. D., & Peterson, L. C. (2002) · American Journal of Clinical Pathology · doi:10.1309/09np-3dfg-blm9-e5le · Cited by 67
Gallicchio, L. M., McSorley, M. A., Newschaffer, C. J., Thuita, L. W., Huang, H., Hoffman, S. C., & Helzlsouer, K. J. (2006) · Cancer · doi:10.1002/cncr.21763 · Cited by 66
Lodgement and extravasation of tumour cells in blood-borne metastasis: an electron microscope study
Kinjo, M. (1978) · British Journal of Cancer · doi:10.1038/bjc.1978.201 · Cited by 66
Lilly, A. J., Johnson, W. E. B., & Bunce, C. M. (2011) · Stem Cells International · doi:10.4061/2011/274564 · Cited by 65
Majka, M., Ratajczak, J., Vilaire, G., Kubiczek, K., Marquez‐Curtis, L. A., Janowska‐Wieczorek, A., & Ratajczak, M. Z. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(02)00810-x · Cited by 65
Regulation of LIM-kinase 1 and cofilin in thrombin-stimulated platelets
Pandey, D. B., Goyal, P., Bamburg, J. R., & Siess, W. (2005) · Blood · doi:10.1182/blood-2004-11-4377 · Cited by 64
Slatore, C. G., Au, D. H., Littman, A. J., Satia, J. A., & White, E. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-1110 · Cited by 64
Schulze, H., Dose, M., Korpal, M., Meyer, I., Italiano, J. E., & Shivdasani, R. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709397200 · Cited by 64
Wynne, J. P., Wu, J., Su, W., Mor, A., Patsoukis, N., Boussiotis, V. A., Hubbard, S. R., & Philips, M. R. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201201157 · Cited by 64
CalDAG-GEFI and platelet activation
Stefanini, L., & Bergmeier, W. (2010) · Platelets · doi:10.3109/09537101003639931 · Cited by 63
Desch, A., Strozyk, E. A., Bauer, A. T., Huck, V., Niemeyer, V., Wieland, T., & Schneider, S. W. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.04.012 · Cited by 63
Nonsteroidal Antiinflammatory Drug Use and Lung Cancer
Khuder, S., Herial, N. A., Mutgi, A. B., & Federman, D. J. (2005) · CHEST Journal · doi:10.1378/chest.127.3.748 · Cited by 63
Adducin in platelets: activation-induced phosphorylation by PKC and proteolysis by calpain
Gilligan, D. M., Sarid, R., & Weese, J. (2002) · Blood · doi:10.1182/blood.v99.7.2418 · Cited by 62
SCL-mediated regulation of the cell-cycle regulator p21 is critical for murine megakaryopoiesis
Chagraoui, H., Kassouf, M. T., Banerjee, S., Goardon, N., Clark, K., Atzberger, A., Pearce, A. C., Skoda, R. C., Ferguson, D. J. P., Watson, S. P., et al. (2011) · Blood · doi:10.1182/blood-2011-01-328765 · Cited by 62
Anomalous megakaryocytopoiesis in mice with mutations in the c-Myb gene
Metcalf, D., Carpinelli, M. R., Hyland, C. D., Mifsud, S., DiRago, L., Nicola, N. A., Hilton, D. J., & Alexander, W. S. (2005) · Blood · doi:10.1182/blood-2004-12-4806 · Cited by 61
Platelets Alter Tumor Cell Attributes to Propel Metastasis: Programming in Transit
Gay, L. J., & Felding‐Habermann, B. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.11.001 · Cited by 61
Zufferey, A., Fontana, P., Reny, J., Nolli, S., & Sanchez, J. (2011) · Mass Spectrometry Reviews · doi:10.1002/mas.20345 · Cited by 61
Effects of prostacyclin on tumor cell-induced platelet aggregation.
Menter, D. G., Onoda, J. M., Taylor, J. D., & Honn, K. V. (1984) · PubMed · Cited by 60
Self-citationOda, A., Miki, H., Wada, I., Yamaguchi, H., Yamazaki, D., Suetsugu, S., Nakajima, M., Nakayama, A., Okawa, K., Miyazaki, H., et al. (2004) · Blood · doi:10.1182/blood-2003-04-1319 · Cited by 60
Bergmeier, W., & Stefanini, L. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283642267 · Cited by 58
Critical role of Src-Syk-PLCγ2 signaling in megakaryocyte migration and thrombopoiesis
Mazharian, A., Thomas, S. G., Dhanjal, T., Buckley, C. D., & Watson, S. P. (2010) · Blood · doi:10.1182/blood-2010-03-275990 · Cited by 58
Kundumani‐Sridharan, V., Dyukova, E., Hansen, D. E., & Rao, G. N. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.453290 · Cited by 57
Varki, A. P., & Varki, N. M. (2001) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2001000600003 · Cited by 57
Shen, J., Gammon, M. D., Terry, M. B., Teitelbaum, S. L., Neugut, A. I., & Santella, R. M. (2006) · Breast Cancer Research · doi:10.1186/bcr1629 · Cited by 56
Study of the effect of metformin on platelet aggregation in insulin-dependent diabetics
Gin, H., Freyburger, G., Boisseau, M., & Aubertin, J. (1989) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(89)90058-2 · Cited by 55
Regular Adult Aspirin Use Decreases the Risk of Non-Small Cell Lung Cancer among Women
Dyke, A. L. V., Coté, M. L., Prysak, G. M., Claeys, G. B., Wenzlaff, A. S., & Schwartz, A. G. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0517 · Cited by 55
Disseminated thrombosis in colon cancer
McKay, D. G., & Wahle, G. H. (1955) · Cancer · doi:10.1002/1097-0142(1955)8:5<970::aid-cncr2820080520>3.0.co;2-k · Cited by 55
The release of vesicles from platelets following adhesion to vessel walls in vitro.
Warren, B. A., & Vales, O. (1972) · PubMed · Cited by 54
Fowler, M., Borazanci, E. H., McGhee, L., Pylant, S. W., Williams, B. J., Glass, J., Davis, J. N., & Meyers, S. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20664 · Cited by 54
Assessing the Risk and Prognosis of Thrombotic Complications in Cancer Patients
Kyriazi, V., & Theodoulou, E. (2013) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2012-0490-ra · Cited by 54
Chen, Y., Aardema, J., Kale, S., Whichard, Z. L., Awomolo, A., Blanchard, E. G., Chang, B., Myers, D. R., Ju, L. A., Tran, R., et al. (2013) · Blood · doi:10.1182/blood-2013-03-484550 · Cited by 54
Axelrad, T. W., Deo, D. D., Ottino, P., Kirk, J. V., Bazan, N. G., Bazán, H. E. P., & Hunt, J. D. (2004) · The FASEB Journal · doi:10.1096/fj.03-0479fje · Cited by 54
The Lysosomal Granule Membrane Protein, Lamp-2, Is also Present in Platelet Dense Granule Membranes
Israels, S. J., McMillan, E. M., Robertson, C. C., Singhroy, S., & McNicol, A. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650333 · Cited by 54
Getz, T. M., Dangelmaier, C., JIN, J., et al. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04000.x · Cited by 53
Role for β3 integrins in human melanoma growth and survival
Trikha, M., Tı́már, J., Zacharek, A., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10521 · Cited by 53
Megakaryopoiesis and Thrombopoiesis: An Update on Cytokines and Lineage Surface Markers
Yu, M., & Cantor, A. B. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-307-3_20 · Cited by 53
Kauskot, A., & Hoylaerts, M. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-29423-5_2 · Cited by 53
Halene, S. (2024) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000799 · Cited by 53
Blood Sphingolipids in Homeostasis and Pathobiology
Hammad, S. M. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0650-1_4 · Cited by 51
The carboxy-terminal pleckstrin homology domain of ROCK interacts with filamin-A
Hamao, K., Ohta, Y., & Hosoya, H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00048-2 · Cited by 50
Targeting Inflammation: Multiple Innovative Ways to Reduce Prostaglandin E 2
Norberg, J. K., Sells, E., Chang, H.-H., Alla, S. R., Zhang, S., & Meuillet, E. J. (2013) · Pharmaceutical Patent Analyst · doi:10.4155/ppa.12.90 · Cited by 50
Translating metastasis-related biomarkers to the clinic—progress and pitfalls
Bidard, F., Pierga, J., Soria, J., & Thiery, J. P. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.4 · Cited by 50
Building blood vessels in development and disease
Kushner, E. J., & Bautch, V. L. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328360614b · Cited by 50
Phosphorylation of CalDAG‐GEFI by protein kinase A prevents Rap1b activation
Subramanian, H., Zahedi, R. P., Sickmann, A., Walter, U., & Gambaryan, S. P. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12271 · Cited by 49
Jurasz, P., Stewart, M. W., Radomski, A. S., Khadour, F., Duszyk, M., & Radomski, M. W. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704343 · Cited by 46
Vanags, D. M., Rodgers, S., Duncan, E. M., Lloyd, J. V., & Bochner, F. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14435.x · Cited by 46
Gerrits, A. J., Gitz, E., Koekman, A. C., Visseren, F. L. J., van Haeften, T. W., & Akkerman, J. N. (2012) · Haematologica · doi:10.3324/haematol.2011.054916 · Cited by 46
Sordat, I., Decraene, C., Silvestre, T., Petermann, O., Auffray, C., Piétu, G., & Sordat, B. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000044350.18215.0d · Cited by 45
Analysis of the Role of Rab27 Effector Slp4‐a/Granuphilin‐a in Dense‐Core Vesicle Exocytosis
Fukuda, M., & Kanno, E. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)03039-9 · Cited by 44
Feng, D., Nagy, J. A., Pyne, K., Dvorak, H. F., & Dvořàk, A. M. (1998) · International Archives of Allergy and Immunology · doi:10.1159/000023944 · Cited by 44
Jackson, S. P. (2000) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(00)00062-1 · Cited by 44
Anticoagulation for prevention and treatment of cancer‐related venous thromboembolism
Barsam, S. J., Patel, R., & Arya, R. (2013) · British Journal of Haematology · doi:10.1111/bjh.12314 · Cited by 43
de Leval, X., Benoît, V., Delarge, J., Julémont, F., Masereel, B., Pirotte, B., Merville, M.-P., David, J., & Dogné, J. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(02)00235-1 · Cited by 43
The critical role of ECM proteins within the human MSC niche in endothelial differentiation
Wang, C.-H., Wang, T., Young, T., Lai, Y., & Yen, M. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.062 · Cited by 42
Goggs, R. A. N., & Poole, A. W. (2012) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/j.1476-4431.2011.00704.x · Cited by 41
Solum, N. O., Ueland, T., Videm, V., Aukrust, P., & Mellembakken, J. R. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616061 · Cited by 39
Cap Z, a calcium insensitive capping protein in resting and activated platelets
Nachmias, V. T., Golla, R., Casella, J. F., & Barron‐Casella, E. A. (1996) · FEBS Letters · doi:10.1016/0014-5793(95)01474-8 · Cited by 39
Uchide, K., Sakon, M., Ariyoshi, H., Nakamori, S., Tokunaga, M., & Monden, M. (2006) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9225-3 · Cited by 38
Chopra, H., Tímár, J., Rong, X., Grossi, I. M., Hatfield, J. S., Fligiel, S., Finch, C. A., Taylor, J. D., & Honn, K. V. (1992) · Clinical & Experimental Metastasis · doi:10.1007/bf00114589 · Cited by 38
Self-citationSleeman, J. P., Cady, B., & Pantel, K. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9489-x · Cited by 37
Pakala, R. (2004) · Cardiovascular Radiation Medicine · doi:10.1016/j.carrad.2003.12.002 · Cited by 36
The β3 integrin cytoplasmic tail: protein scaffold and control freak
Shattil, S. J. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03397.x · Cited by 35
Takayama, M., Fujita, R., Suzuki, M., Okuyama, R., Aiba, S., Motohashi, H., & Yamamoto, M. P. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01304-09 · Cited by 35
Fujita, A., SAITO, Y., Ishizaki, T., Maekawa, M., Fujisawa, K., Ushikubi, F., & Narumiya, S. (1997) · Biochemical Journal · doi:10.1042/bj3280769 · Cited by 35
Lipidomic analysis of platelet senescence
Ruebsaamen, K., Liebisch, G., Boettcher, A., et al. (2010) · Transfusion · doi:10.1111/j.1537-2995.2010.02584.x · Cited by 34
Expression of ABC-type transport proteins in human platelets
Nieen, J., Jedlitschky, G., Grube, M., Kawakami, H., Kamiie, J., Ohtsuki, S., Schwertz, H., Bien, S., Starke, K., Ritter, C. A., et al. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833997b0 · Cited by 34
Gitz, E., Koopman, C. D., Giannas, A., Koekman, A. C., van den Heuvel, D. J., Deckmyn, H., Akkerman, J. N., Gerritsen, H. C., & Urbanus, R. T. (2013) · Haematologica · doi:10.3324/haematol.2013.087221 · Cited by 34
Carpenter, C. L., Tolias, K. F., Couvillon, A. D., & Hartwig, J. H. (1997) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(96)00005-2 · Cited by 33
Krishnan, S., Gaspari, M., Corte, A. D., Bianchi, P., Crescente, M., Cerletti, C., Torella, D., Indolfi, C., de Gaetano, G., Donati, M. B., et al. (2011) · Electrophoresis · doi:10.1002/elps.201000592 · Cited by 33
Procoagulant platelet balloons: evidence from cryopreparation and electron microscopy
Hess, M. W., & Siljander, P. R. M. (2001) · Histochemistry and Cell Biology · doi:10.1007/s004180100272 · Cited by 32
Recent advances in platelet proteomics
Michele, M. D., Geet, C. V., & Freson, K. (2012) · Expert Review of Proteomics · doi:10.1586/epr.12.31 · Cited by 32
Ion channels in the regulation of platelet migration
Schmidt, E.-M., Münzer, P., Borst, O., Kraemer, B. F., Schmid, E., Urban, B., Lindemann, S., Ruth, P., Gawaz, M., & Lang, F. J. W. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.009 · Cited by 31
Visualization and Manipulation of the Platelet and Megakaryocyte Cytoskeleton
Thon, J. N., & Italiano, J. E. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-307-3_9 · Cited by 26
Pandey, D. B., Goyal, P., & Siess, W. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.01.002 · Cited by 25
P-selectin-mediated attachment of small cell lung carcinoma to endothelial cells
Pottratz, S. T., Hall, T. D., Scribner, W. M., et al. (1996) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1996.271.6.l918 · Cited by 23
Lee, J.-J., Yu, J., Lee, J.-H., Zhang, W. Y., Kim, T., Myung, C., & Yun, Y. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-0307-1 · Cited by 22
Proteomics to Unravel Platelet-Related Diseases and Identify Novel Anti-Platelet Drugs
Michele, M. D., Geet, C. V., & Freson, K. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803306312 · Cited by 20
Adjuvant therapy and thrombosis: How to avoid the problem?
Levine, M. N. (2007) · The Breast · doi:10.1016/j.breast.2007.07.012 · Cited by 20
Thrombopoietic Cells and the Bone Marrow Vascular Niche
Kopp, H., & Rafii, S. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1392.004 · Cited by 19
Gefitinib Affects Functions of Platelets and Blood Vesselsvia Changes in Prostanoids Balance
Kanazawa, S., Yamaguchi, K., Kinoshita, Y., Muramatsu, M., Komiyama, Y., & Nomura, S. (2005) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602960501100409 · Cited by 18
Megakaryopoiesis: Transcriptional Insights into Megakaryocyte Maturation
John, C. (2006) · Frontiers in bioscience · doi:10.2741/2210 · Cited by 17
Baker, M., Reynolds, L. E., Robinson, S. D., Lees, D. M., Parsons, M., Elia, G., & Hodivala‐Dilke, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062516 · Cited by 17
Assessment of Megakaryocyte Migration and Chemotaxis
Mazharian, A. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-307-3_19 · Cited by 17
Cell sources for cartilage repair Contribution of the mesenchymal perivascular niche
Díaz‐Flores, L. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s331 · Cited by 15
12(S)-HETE plays a role as a mediator of expression of platelet CD62 (P-selectin)
T, Y. O. H. I. Y. N. F. U. (1998) · Platelets · doi:10.1080/09537109876537 · Cited by 15
Antagonizing IL-6 in Ankylosing Spondylitis: A Short Review
Sakthiswary, R., & Das, S. (2012) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152812800958979 · Cited by 14
Applications and limits of platelet-rich plasma in sports related injuries.
Stanco, D., Viganò, M., Croiset, S. J., & de Girolamo, L. (2012) · PubMed · Cited by 14
Donth, E.-J. (2001) · Springer series in materials science · doi:10.1007/978-3-662-04365-3_2 · Cited by 13
Tetraspanin microdomains: fine-tuning platelet function
Haining, E. J., Yang, J., & Tomlinson, M. G. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390518 · Cited by 13
Tao, L., Zhang, Y., Xi, X., & Kieffer, N. (2010) · Protein & Cell · doi:10.1007/s13238-010-0089-8 · Cited by 13
Human megakaryocytic progenitor cells
Kanz, L., Löhr, G. W., & Fauser, A. (1987) · Journal of Molecular Medicine · doi:10.1007/bf01745383 · Cited by 13
The 2-arachidonoylglycerol effect on myosin light chain phosphorylation in human platelets
Signorello, M. G., Giacobbe, E., Passalacqua, M., & Leoncini, G. (2013) · Biochimie · doi:10.1016/j.biochi.2013.05.003 · Cited by 12
Watson, A. A., & O’Callaghan, C. A. (2011) · Toxins · doi:10.3390/toxins3080991 · Cited by 12
New thrombopoietin receptor agonists for platelet disorders
Homeida, S., Ebdon, C., Batty, P. A., Jackson, B., Kolade, S. O., Bateman, C. M., Peng, Y., & Stasi, R. (2012) · Drugs of today · doi:10.1358/dot.2012.48.4.1740505 · Cited by 11
Kowit, J. D., Linck, R. W., & Kenney, D. M. (1988) · Biology of the Cell · doi:10.1016/0248-4900(88)90002-0 · Cited by 9
Kim, C., & Kim, M. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.05.115 · Cited by 9
Small RNAs as Potential Platelet Therapeutics
Edelstein, L. C., & Bray, P. F. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-29423-5_17 · Cited by 8
Collins, C., & Tzima, E. (2013) · Small GTPases · doi:10.4161/sgtp.24190 · Cited by 5
Research works printed but not linked: 152
- Rados, C. (2004). Beyond bloodletting: FDA gives leeches a medical makeover. FDA Consumer, 38(5), 9.
- Winkel, R., Tajsic, N., Husum, H., Schlageter, M., Hanebuth, G., & Hoffmann, R. (2013). Saphenous perforator flap. Operative Orthopädie und Traumatologie, 25(2), 152–161. · doi:10.1007/s00064-012-0198-z
- Steinhubl, S. R. (2011). Historical observations on the discovery of platelets, platelet function testing and the first antiplatelet agent. Current Drug Targets, 12(12), 1792–1804. · doi:10.2174/138945011797635858
- Addison, W. (1842). On the colourless corpuscles and on the molecules and cytoblasts in the blood. London Med Gaz, 30, 144–152.
- Schultze, M. (1865). Ein heizbarer Objecttisch und seine Verwendung bei Untersuchungen des Blutes. Arch Mikrosc Anatomy, 1, 1–42. · doi:10.1007/bf02961404
- de Gaetano, G. (2001). A new blood corpuscle: an impossible interview with Giulio Bizzozero. Thrombosis and Haemostasis, 86(4), 973–979.
- Bizzozero, G. (1869). Sul midollo delle ossa. Napoli: Tipografia Italiana.
- Osler, W., & Schäfer, E. A. (1873). über einige im Blute vorhandene bacterienbildende Massen. Centralbl Medicine Wissensch, 11, 577–578.
- Howell, W. H. (1890). Observations upon the occurrence, structure, and function of the giant cells of the marrow. Journal of Morphology, 4, 117–130. · doi:10.1002/jmor.1050040106
- Wright, J. H. (1910). The histogenesis of blood platelets. Journal of Morphology, 21, 263–278. · doi:10.1002/jmor.1050210204
- Nakeff, A., & Maat, B. (1974). Separation of megakaryocytes from mouse bone marrow by velocity sedimentation. Blood, 43(4), 591–595. · doi:10.1182/blood.v43.4.591.591
- Pease, D. C. (1956). An electron microscopic study of red bone marrow. Blood, 11(6), 501–526. · doi:10.1182/blood.v11.6.501.501
- Bariety, M. (1947). Trousseau, 1801–1867 (pp. 234–235). Geneva: Mazenod.
- Osler, W., & McCrae, T. (1900). Latent cancer of the stomach. Phil Medical Journal, 5, 245.
- Henderson, P. H., Jr. (1955). Multiple migratory thrombophlebitis associated with ovarian carcinoma. American Journal of Obstetrics and Gynecology, 70(2), 452–453. · doi:10.1016/s0002-9378(16)37699-2
- Jarniou, A. P., & Moreau, A. (1959). Recurrent & migratory thrombophlebitis revealing a secondary cancer with mediastino-pulmonary form. Presse Médicale, 67(27), 1117–1118.
- Jennings, W., & Russel, W. (1948). Phlebothrombosis associated with mucin-producing carcinomas of the tail and body of the pancreas. Archives of Surgery, 56, 186–198. · doi:10.1001/archsurg.1948.01240010191009
- Kenney, W. (1943). The association of carcinoma in the body and tail of the pancreas with multiple venous thrombi. Surgery, 14, 600–609.
- Linquette, M., Mesmacque, R., Fossati, P., Luez, G., & Beghin, B. (1964). Recurrent and migratory venous thromboses. Prog ress in Medical (Paris), 92, 689–698.
- Mainoli, S., & Piccinelli, O. (1956). Migratory thrombophlebitis and malignant tumors; migratory thrombophlebitis occurring during two cases of reticulosarcoma. La Riforma Medica, 70(46), 1330–1334.
- Picard, R., Horeau, J., Guillon, J., & Robin, C. (1959). Migratory thrombophlebitis & bronchopulmonary cancer. Bulletins et Mémoires de la Société Médicale des Hôpitaux de Paris, 75(9–11), 327–329.
- Popesco, I., & Ciobanu, V. (1958). Migratory thrombophlebitis as a manifestation of visceral cancer. La Semaine des Hôpitaux, 34(1), 26–30.
- Rizzo, J. A. (1956). Migratory thrombophlebitis and visceral cancer. Revista de la Asociación Médica Argentina, 70(825–826), 236–238.
- Womack, W. S., & Castellano, C. J. (1952). Migratory thrombophlebitis associated with ovarian carcinoma. American Journal of Obstetrics and Gynecology, 63(2), 467–469. · doi:10.1016/s0002-9378(15)32851-9
- Brugarolas, A., Elias, E. G., Takita, H., Mink, I. B., Mittelman, A., & Ambrus, J. L. (1973). Blood coagulation and fibrinolysis in patients with carcinoma of the lung. Journal of Medicine, 4(2), 96–105.
- Peterson, H. I., Appelgren, K. L., & Rosengren, B. H. (1969). Fibrinogen metabolism in experimental tumours. European Journal of Cancer, 5(6), 535–542. · doi:10.1016/0014-2964(69)90001-2
- Peterson, H. I., Appelgren, K. L., & Rosengren, B. H. (1972). Experimental studies on the mechanisms of fibrinogen uptake in a rat tumour. European Journal of Cancer, 8(6), 677–681. · doi:10.1016/0014-2964(72)90151-x
- Gastpar, H. (1973). Inhibition of “cancer cell stickiness” through bencylan-hydrogen fumarate (fluditate). Fortschritte der Medizin, 91(33), 1322–1328.
- Hilgard, P. (1973). The role of blood platelets in experimental metastases. British Journal of Cancer, 28(5), 429–435. · doi:10.1038/bjc.1973.168
- Warren, B. A. (1973). Environment of the blood-borne tumor embolus adherent to vessel wall. Journal of Medicine, 4(3), 150–177.
- Warren, B. A., & Vales, O. (1972). The adhesion of thromboplastic tumour emboli to vessel walls in vivo. British Journal of Experimental Pathology, 53(3), 301–313.
- Cliffton, E. E., & Grossi, C. E. (1956). Effect of human plasmin on the toxic effects and growth of blood borne metastatis of the Brown-Pearce carcinoma and the V2 carcinoma of rabbit. Cancer, 9(6), 1147–1152. · doi:10.1002/1097-0142(195611/12)9:6<1147::aid-cncr2820090613>3.0.co;2-u
- Johnson, J. H., & Woods, J. R. (1963). An in vitro study of fibrinolytic agents on V2 carcinoma cells and intravascular thrombi in rabbits. Bulletin of the Johns Hopkins Hospital, 113, 335–346.
- Pearce, L., & Brown, W. H. (1923). Studies based on a malignant tumor of the rabbit: V. Metastases. Part 1. Description of the lesions with especial reference to their occurrence and distribution. The Journal of Experimental Medicine, 38(4), 347–366. · doi:10.1084/jem.38.4.347
- Woods, J. R. (1964). Experimental studies of the intravascular dissemination of ascitic V2 carcinoma cells in the rabbit, with special reference to fibrinogen and fibrinolytic agents. Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften, 20, 92–121.
- Fidler, I. J. (1970). Metastasis: quantitative analysis of distribution and fate of tumor embolilabeled with 125 I-5-iodo-2′-deoxyuridine. Journal of the National Cancer Institute, 45(4), 773–782.
- Honn, K. V., Menter, D., Cavanaugh, P. G., Neagos, G., Moilanen, D., Taylor, J. D., et al. (1983). A review of prostaglandins and the treatment of tumor metastasis. Acta Clinica Belgica, 38(1), 53–67. · doi:10.1080/22953337.1983.11718906
- Menter, D. G., Harkins, C., Onoda, J., Riorden, W., Sloane, B. F., Taylor, J. D., et al. (1987). Inhibition of tumor cell induced platelet aggregation by prostacyclin and carbacyclin: an ultrastructural study. Invasion & Metastasis, 7(2), 109–128.
- Cavanaugh, P. G., Sloane, B. F., Bajkowski, A. S., Gasic, G. J., Gasic, T. B., & Honn, K. V. (1983). Involvement of a cathepsin B-like cysteine proteinase in platelet aggregation induced by tumor cells and their shed membrane vesicles. Clinical & Experimental Metastasis, 1(4), 297–307. · doi:10.1007/bf00121192
- Menter, D. G., Hatfield, J. S., Harkins, C., Sloane, B. F., Taylor, J. D., Crissman, J. D., et al. (1987). Tumor cell-platelet interactions in vitro and their relationship to in vivo arrest of hematogenously circulating tumor cells. Clinical & Experimental Metastasis, 5(1), 65–78. · doi:10.1007/bf00116627
- Sloane, B. F., Rozhin, J., Hatfield, J. S., Crissman, J. D., & Honn, K. V. (1987). Plasma membrane-associated cysteine proteinases in human and animal tumors. Experimental Cell Biology, 55(4), 209–224.
- White, J. G. (1967). A simple method for preservation of fine structure in blood cells. Thrombosis et Diathesis Haemorrhagica, 18(3–4), 745–753.
- White, J. G., & Krivit, W. (1967). The canalicular system of blood platelets: apossible sarcoplasmic reticulum. The Journal of Laboratory and Clinical Medicine, 49, 60.
- White, J. G., & Krivit, W. (1967). Changes in platelet microtubules and granules during early clot development. Thrombosis et Diathesis Haemorrhagica. Supplementum, 26, 29–42.
- Grossi, I. M., Fitzgerald, L. A., Kendall, A., Taylor, J. D., Sloane, B. F., & Honn, K. V. (1987). Inhibition of human tumor cell induced platelet aggregation by antibodies to platelet glycoproteins Ib and IIb/IIIa. Proceedings of the Society for Experimental Biology and Medicine, 186(3), 378–383. · doi:10.3181/00379727-186-3-rc1
- Vitrat, N., Letestu, R., Masse, A., Lazar, V., Vainchenker, W., & Debili, N. (2000). Thromboxane synthase has the same pattern of expression as platelet specific glycoproteins during human megakaryocyte differentiation. Thrombosis and Haemostasis, 83(5), 759–768. · doi:10.1055/s-0037-1613905
- Hussein, K., Dralle, W., Theophile, K., Kreipe, H., & Bock, O. (2009). Megakaryocytic expression of miRNA 10a, 17-5p, 20a and 126 in Philadelphia chromosome-negative myeloproliferative neoplasm. Annals of Hematology, 88(4), 325–332. · DOI
- Lin, J., & Zhan, R. (2011). Advance of studies on role of miRNA in hematopoietic regulation and myeloproliferative neoplasms. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 19(4), 1071–1074.
- Kaushansky, K. (1994). The mpl ligand: molecular and cellular biology of the critical regulator of megakaryocyte development. Stem Cells, 12(Suppl 1), 91–96. discussion 96-97.
- Neumann, T. A., & Foote, M. (2000). Megakaryocyte growth and development factor (MGDF): an Mpl ligand and cytokine that regulates thrombopoiesis. Cytokines, Cellular & Molecular Therapy, 6(1), 47–56. · doi:10.1080/13684730050515912
- Dong-Feng, Z., Ting, L., Yong, Z., Cheng, C., Xi, Z., & Pei-Yan, K. (2013). The TPO/c-MPL pathway in the bone marrow may protect leukemia cells from chemotherapy in AML patients. Pathology and Oncology Research. doi: 10.1007/s12253-013-9696-z . · doi:10.1007/s12253-013-9696-z
- Cosgrove, L. J., Sandrin, M. S., Rajasekariah, P., & McKenzie, I. F. (1986). A genomic clone encoding the alpha chain of the OKM1, LFA-1, and platelet glycoprotein IIb-IIIa molecules. Proceedings of the National Academy of Sciences of the United States of America, 83(3), 752–756. · doi:10.1073/pnas.83.3.752
- Fitzgerald, L. A., Poncz, M., Steiner, B., Rall, S. C., Jr., Bennett, J. S., & Phillips, D. R. (1987). Comparison of cDNA-derived protein sequences of the human fibronectin and vitronectin receptor alpha-subunits and platelet glycoprotein IIb. Biochemistry, 26(25), 8158–8165. · doi:10.1021/bi00399a021
- Lanza, F., Kieffer, N., Phillips, D. R., & Fitzgerald, L. A. (1990). Characterization of the human platelet glycoprotein IIIa gene. Comparison with the fibronectin receptor beta-subunit gene. The Journal of Biological Chemistry, 265(30), 18098–18103. · doi:10.1016/s0021-9258(17)44722-3
- Miyazaki, H. (1996). Physiologic role of TPO in thrombopoiesis. Stem Cells, 14(Suppl 1), 133–138. · doi:10.1002/stem.5530140717
- Monzen, S., Takahashi, K., Yoshino, H., Kasai-Eguchi, K., & Kashiwakura, I. (2011). Terminal maturation of megakaryocytes and platelet production by hematopoietic stem cells irradiated with heavy-ion beams. Radiation Research, 176(1), 8–16. · doi:10.1667/rr2392.1
- Wang, W., Gilligan, D. M., Sun, S., Wu, X., & Reems, J. A. (2011). Distinct functional effects for dynamin 3 during megakaryocytopoiesis. Stem Cells and Development, 20(12), 2139–2151. · doi:10.1089/scd.2011.0159
- Patel-Hett, S., Wang, H., Begonja, A. J., Thon, J. N., Alden, E. C., Wandersee, N. J., et al. (2011). The spectrin-based membrane skeleton stabilizes mouse megakaryocyte membrane systems and is essential for proplatelet and platelet formation. Blood, 118(6), 1641–1652. · doi:10.1182/blood-2011-01-330688
- Dhanjal, T. S., Pendaries, C., Ross, E. A., Larson, M. K., Protty, M. B., Buckley, C. D., et al. (2007). A novel role for PECAM-1 in megakaryocytokinesis and recovery of platelet counts in thrombocytopenic mice. Blood, 109(10), 4237–4244. · doi:10.1182/blood-2006-10-050740
- Reddi, A. H., Gay, R., Gay, S., & Miller, E. J. (1977). Transitions in collagen types during matrix-induced cartilage, bone, and bone marrow formation. Proceedings of the National Academy of Sciences of the United States of America, 74(12), 5589–5592. · doi:10.1073/pnas.74.12.5589
- Zou, Z., Schmaier, A. A., Cheng, L., Mericko, P., Dickeson, S. K., Stricker, T. P., et al. (2009). Negative regulation of activated alpha-2 integrins during thrombopoiesis. Blood, 113(25), 6428–6439. · doi:10.1182/blood-2008-08-175356
- Schachtner, H., Calaminus, S. D., Sinclair, A., Monypenny, J., Blundell, M. P., Leon, C., et al. (2013). Megakaryocytes assemble podosomes that degrade matrix and protrude through basement membrane. Blood, 121(13), 2542–2552. · doi:10.1182/blood-2012-07-443457
- Kunert, S., Meyer, I., Fleischhauer, S., Wannack, M., Fiedler, J., Shivdasani, R. A., et al. (2009). The microtubule modulator RanBP10 plays a critical role in regulation of platelet discoid shape and degranulation. Blood, 114(27), 5532–5540. · doi:10.1182/blood-2009-04-216804
- Mazhuga, P. M., & Nosova, L. I. (1975). Proliferative characteristics of the endothelial cells and pericytes from the capillary vessels of rabbit bone marrow. Tsitologiia i Genetika, 9(5), 416–419.
- Lu, X. G., Zhu, L., Wang, W. Q., Zhang, X. H., Zhao, X. Y., Xu, G. B., et al. (2005). Morphological study on the megakaryocytes with nuclear extrusion and nucleocytoplasmic separation in four cases. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 13(6), 1082–1085.
- Hartwig, J. H., & Italiano, J. E., Jr. (2006). Cytoskeletal mechanisms for platelet production. Blood Cells, Molecules & Diseases, 36(2), 99–103. · doi:10.1016/j.bcmd.2005.12.007
- Italiano, J. E., Jr., Bergmeier, W., Tiwari, S., Falet, H., Hartwig, J. H., Hoffmeister, K. M., et al. (2003). Mechanisms and implications of platelet discoid shape. Blood, 101(12), 4789–4796. · doi:10.1182/blood-2002-11-3491
- Premsler, T., Lewandrowski, U., Sickmann, A., & Zahedi, R. P. (2011). Phosphoproteome analysis of the platelet plasma membrane. Methods in Molecular Biology, 728, 279–290. · doi:10.1007/978-1-61779-068-3_19
- Senis, Y., & Garcia, A. (2012). Platelet proteomics: state of the art and future perspective. Methods in Molecular Biology, 788, 367–399. · DOI
- Parguina, A. F., Rosa, I., & Garcia, A. (2012). Proteomics applied to the study of platelet-related diseases: aiding the discovery of novel platelet biomarkers and drug targets. Journal of Proteomics, 76, 275–286. · doi:10.1016/j.jprot.2012.04.043
- Schulz, C., Leuschen, N. V., Frohlich, T., Lorenz, M., Pfeiler, S., Gleissner, C. A., et al. (2010). Identification of novel downstream targets of platelet glycoprotein VI activation by differential proteome analysis: implications for thrombus formation. Blood, 115(20), 4102–4110. · doi:10.1182/blood-2009-07-230268
- Wright, B., Stanley, R. G., Kaiser, W. J., Mills, D. J., & Gibbins, J. M. (2011). Analysis of protein networks in resting and collagen receptor (GPVI)-stimulated platelet sub-proteomes. Proteomics, 11(23), 4588–4592. · DOI
- Steinert, B. W., Tang, D. G., Grossi, I. M., Umbarger, L. A., & Honn, K. V. (1993). Studies on the role of platelet eicosanoid metabolism and integrin alpha IIb beta 3 in tumor-cell-induced platelet aggregation. International Journal of Cancer, 54(1), 92–101. · doi:10.1002/ijc.2910540116
- Radley, J. M., & Hartshorn, M. A. (1987). Megakaryocyte fragments and the microtubule coil. Blood Cells, 12(3), 603–614.
- Escolar, G., Leistikow, E., & White, J. G. (1989). The fate of the open canalicular system in surface and suspension-activated platelets. Blood, 74(6), 1983–1988. · doi:10.1182/blood.v74.6.1983.1983
- Cranmer, S. L., Pikovski, I., Mangin, P., Thompson, P. E., Domagala, T., Frazzetto, M., et al. (2005). Identification of a unique filamin A binding region within the cytoplasmic domain of glycoprotein Ibalpha. The Biochemical Journal, 387(Pt 3), 849–858. · doi:10.1042/bj20041836
- Mangin, P., David, T., Lavaud, V., Cranmer, S. L., Pikovski, I., Jackson, S. P., et al. (2004). Identification of a novel 14-3-3zeta binding site within the cytoplasmic tail of platelet glycoprotein Ibalpha. Blood, 104(2), 420–427. · doi:10.1182/blood-2003-08-2881
- Mu, F. T., Andrews, R. K., Arthur, J. F., Munday, A. D., Cranmer, S. L., Jackson, S. P., et al. (2008). A functional 14-3-3zeta-independent association of PI3-kinase with glycoprotein Ib alpha, the major ligand-binding subunit of the platelet glycoprotein Ib-IX-V complex. Blood, 111(9), 4580–4587. · doi:10.1182/blood-2007-09-111096
- De Caterina, R., Marchetti, P., Bernini, W., Giannarelli, R., Giannessi, D., & Navalesi, R. (1989). The direct effects of metformin on platelet function in vitro. European Journal of Clinical Pharmacology, 37(2), 211–213. · doi:10.1007/bf00558236
- Wiwanitkit, V. (2011). Metformin high dosage and bleeding episode: a clinical case study. Indian Journal of Endocrinology and Metabolism, 15(2), 132–133. · doi:10.4103/2230-8210.81947
- Harper, M. T., & Poole, A. W. (2013). Chloride channels are necessary for full platelet phosphatidylserine exposure and procoagulant activity. Cell Death and Disease, 4, e969. · doi:10.1038/cddis.2013.495
- Tamaru, S., Fukuta, T., Kaibuchi, K., Matsuoka, Y., Shiku, H., & Nishikawa, M. (2005). Rho-kinase induces association of adducin with the cytoskeleton in platelet activation. Biochemical and Biophysical Research Communications, 332(2), 347–351. · doi:10.1016/j.bbrc.2005.04.127
- Lind, S. E., Yin, H. L., & Stossel, T. P. (1982). Human platelets contain gelsolin. A regulator of actin filament length. Journal of Clinical Investigation, 69(6), 1384–1387. · doi:10.1172/jci110578
- Wang, L. L., & Bryan, J. (1981). Isolation of calcium-dependent platelet proteins that interact with actin. Cell, 25(3), 637–649. · doi:10.1016/0092-8674(81)90171-9
- Davidson, M. M., & Haslam, R. J. (1994). Dephosphorylation of cofilin in stimulated platelets: roles for a GTP-binding protein and Ca2+. The Biochemical Journal, 301(Pt 1), 41–47. · doi:10.1042/bj3010041
- White, J. G. (1972). Exocytosis of secretory organelles from blood platelets incubated with cationic polypeptides. The American Journal of Pathology, 69(1), 41–54.
- White, J. G., & Estensen, R. D. (1972). Degranulation of discoid platelets. The American Journal of Pathology, 68(2), 289–302.
- Marks, M. S. (2012). SNARing platelet granule secretion. Blood, 120(12), 2355–2357. · doi:10.1182/blood-2012-07-442756
- Fukami, M. H., & Salganicoff, L. (1977). Human platelet storage organelles. A review. Thrombosis and Haemostasis, 38(4), 963–970. · doi:10.1055/s-0038-1651914
- Emiliani, C., Martino, S., Orlacchio, A., Vezza, R., Nenci, G. G., & Gresele, P. (1995). Platelet glycohydrolase activities: characterization and release. Cell Biochemistry and Function, 13(1), 31–39. · doi:10.1002/cbf.290130108
- Gordon, J. L. (1975). Blood platelet lysosomes and their contribution to the pathophysiological role of platelets. Frontiers of Biology, 43(4), 3–31.
- Metzelaar, M. J., & Clevers, H. C. (1992). Lysosomal membrane glycoproteins in platelets. Thrombosis and Haemostasis, 68(4), 378–382. · doi:10.1055/s-0038-1646280
- Waite, M., & Griffin, H. D. (1976). The phospholipases A of lysosomes. Frontiers of Biology, 45, 257–305.
- Sabetkar, M., Naseem, K. M., Tullett, J. M., Friebe, A., Koesling, D., & Bruckdorfer, K. R. (2001). Synergism between nitric oxide and hydrogen peroxide in the inhibition of platelet function: the roles of soluble guanylyl cyclase and vasodilator-stimulated phosphoprotein. Nitric Oxide, 5(3), 233–242. · doi:10.1006/niox.2001.0343
- Dutta-Roy, A. K., & Sinha, A. K. (1987). Purification and properties of prostaglandin E1/prostacyclin receptor of human blood platelets. The Journal of Biological Chemistry, 262(26), 12685–12691. · doi:10.1016/s0021-9258(18)45261-1
- Dittrich, M., Birschmann, I., Mietner, S., Sickmann, A., Walter, U., & Dandekar, T. (2008). Platelet protein interactions: map, signaling components, and phosphorylation groundstate. Arteriosclerosis, Thrombosis, and Vascular Biology, 28(7), 1326–1331. · doi:10.1161/atvbaha.107.161000
- Yamanaka, M., Kume, S., Kariya, T., & Tanabe, A. (1979). cAMP-dependent protein kinase in human platelets and effect of prostaglandin E1 on its endogenous substrates (author’s transl). Nihon Ketsueki Gakkai Zasshi, 42(3), 541–542.
- Sand, C., Grandoch, M., Borgermann, C., Oude Weernink, P. A., Mahlke, Y., Schwindenhammer, B., et al. (2010). 8-pCPT-conjugated cyclic AMP analogs exert thromboxane receptor antagonistic properties. Thrombosis and Haemostasis, 103(3), 662–678. · doi:10.1160/th09-06-0341
- Siess, W., Winegar, D. A., & Lapetina, E. G. (1990). Rap1-B is phosphorylated by protein kinase A in intact human platelets. Biochemical and Biophysical Research Communications, 170(2), 944–950. · doi:10.1016/0006-291x(90)92182-y
- Marquis, N. R., Vigdahl, R. L., & Tavormina, P. A. (1969). Platelet aggregation. I. Regulation by cyclic AMP and prostaglandin E1. Biochemical and Biophysical Research Communications, 36(6), 965–972. · doi:10.1016/0006-291x(69)90298-8
- Salzman, E. W. (1967). ADP-platelet aggregation. Thrombosis et Diathesis Haemorrhagica. Supplementum, 26, 197–199.
- Brodie, G. N., Baenziger, N. L., Chase, L. R., & Majerus, P. W. (1972). The effects of thrombin on adenyl cyclase activity and a membrane protein from human platelets. The Journal of Clinical Investigation, 51(1), 81–88. · doi:10.1172/jci106800
- Watanabe, N. (2010). RIAM: bridge between Rap1 and integrin. Rinshō Ketsueki, 51(6), 377–383.
- Huang, J. S., Dong, L., Kozasa, T., & Le Breton, G. C. (2007). Signaling through G(alpha)13 switch region I is essential for protease-activated receptor 1-mediated human platelet shape change, aggregation, and secretion. The Journal of Biological Chemistry, 282(14), 10210–10222. · doi:10.1074/jbc.m605678200
- Itoh, K., Hara, T., & Shibata, N. (1992). Diphosphorylation of platelet myosin by myosin light chain kinase. Biochimica et Biophysica Acta, 1133(3), 286–292. · doi:10.1016/0167-4889(92)90049-h
- Coburn, L. A., Damaraju, V. S., Dozic, S., Eskin, S. G., Cruz, M. A., & McIntire, L. V. (2011). GPIbalpha-vWF rolling under shear stress shows differences between type 2B and 2M von Willebrand disease. Biophysical Journal, 100(2), 304–312. · doi:10.1016/j.bpj.2010.11.084
- Colace, T. V., & Diamond, S. L. (2013). Direct observation of von Willebrand factor elongation and fiber formation on collagen during acute whole blood exposure to pathological flow. Arteriosclerosis, Thrombosis, and Vascular Biology, 33(1), 105–113. · doi:10.1161/atvbaha.112.300522
- Clemetson, K. J. (2007). A short history of platelet glycoprotein Ib complex. Thrombosis and Haemostasis, 98(1), 63–68.
- Bernard, J., & Soulier, J. (1948). Sur une nouvelle variété de dystrophie thrombocytaire-hémorragipare congénitale. Semin Hôp Paris, 24, 3217–3223.
- Gardiner, E. E., Arthur, J. F., Berndt, M. C., & Andrews, R. K. (2005). Role of calmodulin in platelet receptor function. Current Medicinal Chemistry. Cardiovascular and Hematological Agents, 3(4), 283–287. · doi:10.2174/156801605774322283
- De Ceunynck, K., De Meyer, S. F., & Vanhoorelbeke, K. (2013). Unwinding the von Willebrand factor strings puzzle. Blood, 121(2), 270–277. · doi:10.1182/blood-2012-07-442285
- Nurden, A. T., & Caen, J. P. (1974). An abnormal platelet glycoprotein pattern in three cases of Glanzmann’s thrombasthenia. British Journal of Haematology, 28(2), 253–260. · doi:10.1111/j.1365-2141.1974.tb06660.x
- Phillips, D. R., Jenkins, C. S., Luscher, E. F., & Larrieu, M. (1975). Molecular differences of exposed surface proteins on thrombasthenic platelet plasma membranes. Nature, 257(5527), 599–600. · doi:10.1038/257599a0
- Glanzmann, E. (1918). Hereditare hammorhagische thrombastehnie. Beitr Pathologie Bluplatchen J Kinderkt, 88, 113–141.
- Clemetson, K. J. (1995). Platelet activation: signal transduction via membrane receptors. Thrombosis and Haemostasis, 74(1), 111–116. · doi:10.1055/s-0038-1642662
- Asselin, J., Knight, C. G., Farndale, R. W., Barnes, M. J., & Watson, S. P. (1999). Monomeric (glycine-proline-hydroxyproline)10 repeat sequence is a partial agonist of the platelet collagen receptor glycoprotein VI. The Biochemical Journal, 339(Pt 2), 413–418. · doi:10.1042/0264-6021:3390413
- Zahid, M., Mangin, P., Loyau, S., Hechler, B., Billiald, P., Gachet, C., et al. (2012). The future of glycoprotein VI as an antithrombotic target. Journal of Thrombosis and Haemostasis, 10(12), 2418–2427. · doi:10.1111/jth.12009
- Ordonez, N. G. (2013). Value of podoplanin as an immunohistochemical marker in tumor diagnosis: a review and update. Applied Immunohistochemistry & Molecular Morphology.
- Watson, A. A., & O'Callaghan, C. A. (2005). Crystallization and X-ray diffraction analysis of human CLEC-2. Acta Crystallographica. Section F, Structural Biology and Crystallization Communications, 61(Pt 12), 1094–1096. · doi:10.1107/s1744309105037991
- Suzuki-Inoue, K., Inoue, O., & Ozaki, Y. (2011). The novel platelet activation receptor CLEC-2. Platelets, 22(5), 380–384. · doi:10.3109/09537104.2011.556274
- Zimmermann, H. (1999). Nucleotides and cd39: principal modulatory players in hemostasis and thrombosis. Nature Medicine, 5(9), 987–988. · doi:10.1038/12419
- Nathan, P. (1973). The migration of human platelets in vitro. Thrombosis et Diathesis Haemorrhagica, 30(1), 173–177.
- Brown, P. (2005). Lymphatic system: unlocking the drains. Nature, 436(7050), 456–458. · doi:10.1038/436456a
- Bouvenot, G., Escande, M., Xeridat, B., Simonin, G., Boucoiran, J., & Delboy, C. (1977). Thrombocytosis and cancer. Apropos of a chronological series of 100 patients. La Semaine des Hôpitaux, 53(36), 1921–1925.
- Rank, A., Liebhardt, S., Zwirner, J., Burges, A., Nieuwland, R., & Toth, B. (2012). Circulating microparticles in patients with benign and malignant ovarian tumors. Anticancer Research, 32(5), 2009–2014.
- van Doormaal, F., Kleinjan, A., Berckmans, R. J., Mackman, N., Manly, D., Kamphuisen, P. W., et al. (2012). Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study. Thrombosis and Haemostasis, 108(1), 160–165. · doi:10.1160/th12-02-0099
- Rank, A., Nieuwland, R., Roesner, S., Nikolajek, K., Hiller, E., & Toth, B. (2012). Climacteric lowers plasma levels of platelet-derived microparticles: a pilot study in pre- versus postmenopausal women. Acta Haematologica, 128(1), 53–59. · doi:10.1159/000337327
- Green, D. L., & Karpatkin, S. (2009). Effect of cancer on platelets. Cancer Treatment and Research, 148, 17–30. · DOI
- Grignani, G., Pacchiarini, L., Almasio, P., Pagliarino, M., Gamba, G., Rizzo, S. C., et al. (1986). Characterization of the platelet-aggregating activity of cancer cells with different metastatic potential. International Journal of Cancer, 38(2), 237–244. · doi:10.1002/ijc.2910380214
- Pacchiarini, L., Zucchella, M., Milanesi, G., Tacconi, F., Bonomi, E., Canevari, A., et al. (1991). Thromboxane production by platelets during tumor cell-induced platelet activation. Invasion & Metastasis, 11(2), 102–109.
- Tzanakakis, G. N., Krambovitis, E., Tsatsakis, A. M., & Vezeridis, M. P. (2002). The preventive effect of ketoconazole on experimental metastasis from a human pancreatic carcinoma may be related to its effect on prostaglandin synthesis. International Journal of Gastrointestinal Cancer, 32(1), 23–30. · DOI
- Gordon, S. G., & Chelladurai, M. (1992). Non-tissue factor procoagulants in cancer cells. Cancer Metastasis Reviews, 11(3–4), 267–282. · DOI
- Kirwan, C. C., McDowell, G., McCollum, C. N., Kumar, S., & Byrne, G. J. (2008). Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancer. British Journal of Cancer, 99(7), 1000–1006. · doi:10.1038/sj.bjc.6604620
- Starakis, I., Koutras, A., & Mazokopakis, E. E. (2010). Drug-induced thromboembolic events in patients with malignancy. Cardiovascular & Hematological Disorders Drug Targets, 10(2), 94–102. · doi:10.2174/187152910791292493
- Anand, M., & Brat, D. J. (2012). Oncogenic regulation of tissue factor and thrombosis in cancer. Thrombosis Research, 129(Suppl 1), S46–49. · doi:10.1016/s0049-3848(12)70015-4
- Ogiichi, T., Hirashima, Y., Nakamura, S., Endo, S., Kurimoto, M., & Takaku, A. (2000). Tissue factor and cancer procoagulant expressed by glioma cells participate in their thrombin-mediated proliferation. Journal of Neuro-Oncology, 46(1), 1–9. · doi:10.1023/a:1006323200001
- Jurasz, P., North, S., Venner, P., & Radomski, M. W. (2003). Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer: a preliminary study. Thrombosis Research, 112(1–2), 59–64. · doi:10.1016/j.thromres.2003.10.012
- Lindenmeyer, F., Legrand, Y., & Menashi, S. (1997). Upregulation of MMP-9 expression in MDA-MB231 tumor cells by platelet granular membrane. FEBS Letters, 418(1–2), 19–22. · doi:10.1016/s0014-5793(97)01336-7
- Oleksowicz, L., Mrowiec, Z., Schwartz, E., Khorshidi, M., Dutcher, J. P., & Puszkin, E. (1995). Characterization of tumor-induced platelet aggregation: the role of immunorelated GPIb and GPIIb/IIIa expression by MCF-7 breast cancer cells. Thrombosis Research, 79(3), 261–274. · doi:10.1016/0049-3848(95)00113-6
- Timar, J., Trikha, M., Szekeres, K., Bazaz, R., & Honn, K. (1998). Expression and function of the high affinity alphaIIbbeta3 integrin in murine melanoma cells. Clinical & Experimental Metastasis, 16(5), 437–445. · doi:10.1023/a:1006533508560
- Trikha, M., Timar, J., Lundy, S. K., Szekeres, K., Cai, Y., Porter, A. T., et al. (1997). The high affinity alphaIIb beta3 integrin is involved in invasion of human melanoma cells. Cancer Research, 57(12), 2522–2528.
- Iwamura, T., Caffrey, T. C., Kitamura, N., Yamanari, H., Setoguchi, T., & Hollingsworth, M. A. (1997). P-selectin expression in a metastatic pancreatic tumor cell line (SUIT-2). Cancer Research, 57(6), 1206–1212.
- Goschnick, M. W., & Jackson, D. E. (2007). Tetraspanins-structural and signalling scaffolds that regulate platelet function. Mini Reviews in Medicinal Chemistry, 7(12), 1248–1254. · doi:10.2174/138955707782795656
- Billroth, T. (1878). Lectures on surgical pathology and therapeutics, a handbook for students and practitioners (vol. II). London: The New Sydenham Society.
- Baserga, R., & Saffiotti, U. (1955). Experimental studies on histogenesis of blood-borne metastases. AMA Archives of Pathology, 59(1), 26–34.
- Chew, E. C., & Wallace, A. C. (1976). Demonstration of fibrin in early stages of experimental metastases. Cancer Research, 36(6), 1904–1909.
- Warren, B. A. (1976). Some aspects of blood borne tumour emboli associated with thrombosis. Zeitschrift für Krebsforschung und Klinische Onkologie. Cancer Research and Clinical Oncology, 87(1), 1–15.
- Oleksowicz, L., & Dutcher, J. P. (1995). Adhesive receptors expressed by tumor cells and platelets: novel targets for therapeutic anti-metastatic strategies. Medical Oncology, 12(2), 95–102. · doi:10.1007/bf01676709
- Lonsdorf, A. S., Kramer, B. F., Fahrleitner, M., Schonberger, T., Gnerlich, S., Ring, S., et al. (2012). Engagement of alphaIIbbeta3 (GPIIb/IIIa) with alphanubeta3 integrin mediates interaction of melanoma cells with platelets: a connection to hematogenous metastasis. The Journal of Biological Chemistry, 287(3), 2168–2178. · doi:10.1074/jbc.m111.269811
- Beleva, E., & Grudeva-Popova, J. (2013). From Virchow’s triad to metastasis: circulating hemostatic factors as predictors of risk for metastasis in solid tumors. Journal of BUON, 18(1), 25–33.
- Jafari, S., Etminan, M., & Afshar, K. (2009). Nonsteroidal anti-inflammatory drugs and prostate cancer: a systematic review of the literature and meta-analysis. Canadian Urological Association Journal, 3(4), 323–330. · DOI
- Chan, A. T., Zauber, A. G., Hsu, M., Breazna, A., Hunter, D. J., Rosenstein, R. B., et al. (2009). Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma. Gastroenterology. doi: 10.1053/j.gastro.2009.02.045 . · DOI
Cited by
Role of platelets and platelet receptors in cancer metastasis
Schlesinger, M. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0669-2 · Cited by 690
Enzyme-powered Janus platelet cell robots for active and targeted drug delivery
Tang, S., Zhang, F., Gong, H., Wei, F., Zhuang, J., Karshalev, E., Esteban-Fernández de Ávila, B., Huang, C., Zhou, Z., Li, Z., et al. (2020) · Science Robotics · doi:10.1126/scirobotics.aba6137 · Cited by 427
Gonzalez-Avila, G., Sommer, B., Mendoza-Posada, D. A., Ramos, C., Garcia-Hernandez, A. A., & Falfan-Valencia, R. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.02.010 · Cited by 373
Okugawa, Y., Toiyama, Y., Yamamoto, A., Shigemori, T., Ide, S., Kitajima, T., Fujikawa, H., Yasuda, H., Hiro, J., Yoshiyama, S., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003239 · Cited by 280
Platelets, Thrombo-Inflammation, and Cancer: Collaborating With the Enemy
Palacios-Acedo, A. L., Mège, D., Crescence, L., Dignat-George, F., Dubois, C., & Panicot-Dubois, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01805 · Cited by 273
Metadata
- Authors
- Menter, D. G., Tucker, S. C., Kopetz, S., Sood, A. K., Crissman, J. D., & Honn, K. V.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2014-03
- Volume
- 33
- Issue
- 1
- Pages
- 231-269
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W2079629625
- Cited by
- 316
- References
- 389
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.